Rep. Katie Porter Says ‘Two Manufacturers Control 97%’ Of Covid-19 Vaccine Market [Forbes]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Forbes
In a recent speech, Rep. Katie Porter (D-California) said, “We cannot continue to ask taxpayers to... [+]help cover the risk while letting Pharma collude to reap the profits.” Porter is seen here during a different speech on November 8, 2022.(Photo by Mindy Schauer/MediaNews Group/Orange County Register via Getty Images)MediaNews Group via Getty ImagesRep. Katie Porter (D-California) had some choice words about pharmaceutical companies when it comes to the choice of Covid-19 vaccines. In a recent speech to her Congressional colleagues, she referred to the recent revelation that Pfizer and Moderna may raise the roof on Covid-19 mRNA vaccine prices four-fold up to the $110 to $130 per dose range,which I’ve covered for ForbesPorter shared a video clip of her speech via the following tweet:As you can see, the clip began a big opening: “I rise today in strong opposition to Big Pharma cheating taxpayers.” A little later in the clip, Porter emphasized, “Taxpayers contributed to
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau [Yahoo! Finance]Yahoo! Finance
- Cramer explains how to maintain a ‘balanced' portfolio as the economy slows [CNBC]CNBC
- Pfizer Pauses Gene Therapy Trial for Muscle Disease After Death [BNN Bloomberg (Canada)]BNN Bloomberg
- Pfizer wants the $75 mln left from SAC Capital's insider trading settlement with SEC [Reuters]Reuters
- Pfizer Dividend Yield Pushes Past 6% [Forbes]Forbes
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/1/24 - Form 4
- 5/1/24 - Form 4
- 5/1/24 - Form 8-K
- PFE's page on the SEC website